Immunological aspects of persistent hepatitis B in children
Abstract
We studied the immunological status of 203 children having persistence Hepatitis B (positive HBsAg) ranging in age from 6 to 14 years in Semarang Municipality. The results of humoral immunity examination (IgM Anti-HBc) showed that all were negative, indicating that they are not in acute phase of hepatitis B infection. Cellular immunity examination, i.e., CMI skin test has shown positive result in 64.9% on persistent and 65.2% in non persistent hepatitis B (p>0.05). T cell examination showed statistically significant difference (p<0.01) between persistenct and non persistent hepatitis B patients, there was is also significant difference (p<0.01) on CD4 cell examination. These findings indicated that there was difference in immunoregulation function and response repression of antivirus between both groups of patients. On the other hand CD4/ CD8 ratio and T cell function showed no significant difference between the two gorups of patients; similarly the specific function of cytotoxic T cell was not significantly difference.
References
23.
2. Alberti SA, Diana S, Eddleston ALWF, Scullard GH. Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection. BMJ 1978; 2:1056-58.
3. Dientag JL. Immunologic mechanism in chronic viral hepatitis. In: Vyas GN, Dientag JL, Hoofnagle J, editors. Viral Hepatitis and Liver Disease. New York: Grune and Stratton Inc., 1984;135-164.
4. Eddleston ALWF, Mondelli M, Mieli-Vergan IG, Alpert A. et al. Lymphocytes cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection. Hepatology
1982;2:122S-127S.
5. Eddleston ALWF. Immunological aspects of hepatitis B infection. In: Zuckerman A, Allan R, editors. Viral hepatitis and liver diseases. New York: Liss Inc., 1988;603-605.
6. Kiyosawa K, Wada S, Imai Y, et al. Significance of IgM antibody to hepatitis B core antigen for the differential diagnosis of acute and chronic hepatitis B virus infection and for the evaluation of the inflammatory activity of type B chronic liver diseases. Gastroenterology Japonica 1986;21:6.
7. Brunetto MR, Cerenzia MT, Oliveri F, et al. Monitoring the natural caurse and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. J. Hepatol 1993;19:431-436.
8. Barnaba W, Musca A, Cordova C, Levrero M, Ruocco G, Balsanof. Relationship betwee n T cell subsets and supressor cell activity in chronic hepatitis B virus infection.
Clin. Exp. Immunol.1983;53:281-288.
9. Neurath AR., Kent S.B.H., Strick N. The biological role of pre-S sequences in the hepatitis B virus envelope protein : Implication for vaccine design. Proceeding of Asian
symposium on strategies for large scale Hepatitis B immunization. Hong Kong June 12-13, 1986;97-112.
10. Stites DP and Terr AI. Basic and clinical immunology. Prentice-Hall Intern. Inc. USA. 1991.
11. Dienfeng Z, Bangyuan L, Zuchong L and Fengsheng C. Cell-mediated immune response in viral hepatitis B. Chinese Med. J 1980;2:90-97.
12. Dienstag JL. Immunologic mechanism in chronic viral hepatitis. In: Vyas GN, Dientag JL, Hoofnagle JH, editors. Viral hepatitis and liver disease. New York: Grune & Stratton Inc.,1984.
13. Eddleston ALEF. Overview of HBV pathogenesis. In: Hollinger FB, Lemon SM, Margolis H, editors. Viral hepatitis and liver disease. Baltimore: Williams & Wilkins, 1990.
14. Aoyama K, Kojima T, Inoue K, Sasaki H. Immunohistochemical investigation of hepatitis B virus associated antigens, HLA antigens and lymphocyte subsets in type B chronic hepatitis. Gastroenterologia Japonica 1990;25:41-53.
15. Mondelli M, Vergai GM, Alberti A, et al. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection : evidence that T cells
are directed against HBV core antigen expressed on hepatocytes. J. Immun. 1982;129:6.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Accepted 2016-11-23
Published 2006-08-30
